A Polydiacetylene Microchip Based on a Biotin-Streptavidin Interaction for the Diagnosis of Pathogen Infections

A micropatterned polydiacetylene (PDA) chip, utilizing the unique fluorogenic property of PDA and a specific biotin–streptavidin (STA) interaction, is constructed to detect pathogen infections. To construct the PDA chip, biotin‐modified diacetylene liposomes are immobilized on aldehyde glass and con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Small (Weinheim an der Bergstrasse, Germany) Germany), 2008-10, Vol.4 (10), p.1778-1784
Hauptverfasser: Jung, Yun Kyung, Kim, Tae Won, Jung, Cheulhee, Cho, Dae-Yeon, Park, Hyun Gyu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A micropatterned polydiacetylene (PDA) chip, utilizing the unique fluorogenic property of PDA and a specific biotin–streptavidin (STA) interaction, is constructed to detect pathogen infections. To construct the PDA chip, biotin‐modified diacetylene liposomes are immobilized on aldehyde glass and conjugated with STA, followed by UV irradiation to polymerize the STA‐functionalized diacetylene liposomes. Genomic DNA of a model pathogen, Chlamydia trachomatis, is isolated from human samples and biotin‐labeled target DNA is obtained through PCR amplification using biotin‐11‐dUTP. Owing to the stimulus caused by the biotin–STA interaction, the biotinylated DNA induces an intense fluorescence signal on the immobilized PDA. By using this strategy, it is possible to diagnose Chlamydia infections by applying DNA samples from several nonhealthy humans to a single PDA chip. The results of this study serve as the basis for a new strategy for fluorogenic PDA microarray‐based diagnosis of pathogen infections. A novel fluorogenic streptavidin‐functionalized polydiacetylene (PDA) microchip is designed to generate fluorescence signals only when interacting with biotinylated target DNA (see image). Since the fluorescence is generated from the fluorogenic transition of the PDAs, the strategy does not require complex labeling steps. Its clinical utility is successfully demonstrated by correctly diagnosing Chlamydia infections of several samples on a single PDA microchip.
ISSN:1613-6810
1613-6829
DOI:10.1002/smll.200800947